MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 17, Issue 9, Pages 1073-1080
Publisher
Informa Healthcare
Online
2013-07-19
DOI
10.1517/14728222.2013.819853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells
- (2014) Mei Mei et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Inhibition of miR-21 Induces Biological and Behavioral Alterations in Diffuse Large B-Cell Lymphoma
- (2013) Ling Gu et al. ACTA HAEMATOLOGICA
- Functionalized Graphene Oxide Mediated Adriamycin Delivery and miR-21 Gene Silencing to Overcome Tumor Multidrug Resistance In Vitro
- (2013) Feng Zhi et al. PLoS One
- miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN
- (2013) Shou-mei Yang et al. TOXICOLOGY
- Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth
- (2012) Yan-Xia Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- MiRNA-21
- (2012) Wen Gao et al. CANCER BIOLOGY & THERAPY
- Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
- (2012) Bin Bao et al. CURRENT DRUG TARGETS
- Immunotherapy: A useful strategy to help combat multidrug resistance
- (2012) Tyler J. Curiel DRUG RESISTANCE UPDATES
- High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer
- (2012) Miaomiao Yang et al. EUROPEAN JOURNAL OF CANCER
- Angiogenesis-related microRNAs in colon cancer
- (2012) Liu Hong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Drug resistance-related microRNAs in esophageal cancer
- (2012) Liu Hong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- miR-210: a therapeutic target in cancer
- (2012) Liu Hong et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Inductive microRNA-21 impairs anti-mycobacterial responses by targeting IL-12 and Bcl-2
- (2012) Zhongwen Wu et al. FEBS LETTERS
- MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
- (2012) Pedro M. Costa et al. HUMAN MOLECULAR GENETICS
- MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen
- (2012) Haitao Bai et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells
- (2012) Yun Chen et al. JOURNAL OF PEDIATRIC SURGERY
- Clinical Outcome Prediction by MicroRNAs in Human Cancer: A Systematic Review
- (2012) Viswam S. Nair et al. JNCI-Journal of the National Cancer Institute
- Growth Inhibition by miR-519 via Multiple p21-Inducing Pathways
- (2012) K. Abdelmohsen et al. MOLECULAR AND CELLULAR BIOLOGY
- Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
- (2012) Xiaomin Qian et al. MOLECULAR PHARMACEUTICS
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression
- (2012) Hao Li et al. PHARMACEUTICAL BIOLOGY
- Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
- (2012) Sandeep Sheth et al. PLoS One
- miRNAs as mediators of drug resistance
- (2012) Sierk Haenisch et al. Epigenomics
- Bcl-2 Upregulation Induced by miR-21 Via a Direct Interaction Is Associated with Apoptosis and Chemoresistance in MIA PaCa-2 Pancreatic Cancer Cells
- (2011) Jie Dong et al. ARCHIVES OF MEDICAL RESEARCH
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- A systematic-analysis of predicted miR-21 targets identifies a signature for lung cancer
- (2011) W. Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA-21: A novel therapeutic target in human cancer
- (2011) Xuan Pan et al. CANCER BIOLOGY & THERAPY
- MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF R2) in colon cancer cells
- (2011) Y. Yu et al. CARCINOGENESIS
- The transcriptional regulation of miR-21, its multiple transcripts and their implication in prostate cancer
- (2011) Judit Ribas et al. CELL CYCLE
- Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis
- (2011) Xiaonan Fu et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors
- (2011) Hiroshi Tazawa et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
- (2011) Xudong Wang et al. LEUKEMIA & LYMPHOMA
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
- (2011) L Y W Bourguignon et al. ONCOGENE
- Apoptosis and the target genes of microRNA-21
- (2011) Lindsey E. Becker Buscaglia et al. Chinese Journal of Cancer
- Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells
- (2010) Guo-hai Shi et al. ACTA PHARMACOLOGICA SINICA
- MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity
- (2010) Lei Shi et al. BRAIN RESEARCH
- MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
- (2010) Y Tomimaru et al. BRITISH JOURNAL OF CANCER
- Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis
- (2010) Yumin Li et al. CANCER SCIENCE
- Intracellular and Extracellular MicroRNAs in Breast Cancer
- (2010) C. Corcoran et al. CLINICAL CHEMISTRY
- MicroRNA-21: From Cancer to Cardiovascular Disease
- (2010) Virginija Jazbutyte et al. CURRENT DRUG TARGETS
- The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas
- (2010) Liu Hong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Targeting miR-21 in glioma: a small RNA with big potential
- (2010) Lynette M Moore et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
- (2010) Haitao Bai et al. FEBS LETTERS
- Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis
- (2010) Yumin Li et al. Hematology
- MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand
- (2010) Danish Sayed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of miR-21 Promotes an In vitro Metastatic Phenotype by Targeting the Tumor Suppressor RHOB
- (2010) Erin C. Connolly et al. MOLECULAR CANCER RESEARCH
- Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
- (2010) Jin-Hyeok Hwang et al. PLoS One
- MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
- (2010) N. Valeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BMPRII is a direct target of miR-21
- (2009) W. Qin et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells
- (2009) Tao Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-21as a key regulator of oncogenic processes
- (2009) S. Duygu Selcuklu et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme
- (2009) Yiming Li et al. BRAIN RESEARCH
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
- (2009) P. Wang et al. CANCER RESEARCH
- Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma
- (2009) Min Liu et al. CELL RESEARCH
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
- (2009) T. Moriyama et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
- (2008) T. Papagiannakopoulos et al. CANCER RESEARCH
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
- (2008) G. Gabriely et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now